Intel launched the Core Series 2 processors with P-cores at Embedded World 2026, targeting industrial edge applications that require deterministic real-time performance alongside AI workloads. The lineup spans 11 SKUs with up to 12 P-cores, 5.9 GHz turbo, 192GB DDR5-5600 with ECC, up to 16 PCIe Gen 5 lanes, and a 10-year longevity program, claiming up to 4.4x lower PCIe latency and 2.5x more deterministic response time versus AMD Ryzen 7 9700X. Intel also previewed the Health & Life Sciences Edge AI Suite, which provides validated reference pipelines for multimodal patient-monitoring applications, including ECG arrhythmia detection and remote photoplethysmography. A preview is available on GitHub, with general availability planned for Q2 2026.



Leave a Reply